This bill expands retirement benefits under Maine's 1998 Special Plan to include certain community mental health workers employed by the Department of Health and Human Services. Specifically, it adds Mental Health Workers I through IV and Community Response Workers who provide crisis services to adults with developmental or intellectual disabilities to the list of eligible employees. To qualify for these benefits, workers must have been employed in these roles after September 30, 2025, and meet either age and service requirements or have completed at least 25 years of creditable service. The changes apply to employees hired on or after October 1, 2025, or those who held the specified job classifications on that date.
This bill changes prior authorization rules for health insurance plans to improve access to ongoing treatments. It requires that prior authorizations for chronic conditions or long-term care remain valid for the full treatment duration or one year (whichever is longer), and prohibits renewal more frequently than once every five years for treatments lasting over a year. It also prevents health plans from restricting coverage for previously approved medications within 90 days of switching plans, unless the patient's condition changes, and mandates 90 days' notice before any coverage restriction. The bill directly affects patients with chronic conditions and health insurance carriers in Maine.
This bill requires medical cannabis dispensaries and caregivers to test all cannabis products before selling them to patients, ensuring they meet safety standards for contaminants like pesticides, microbes, and THC potency (max 10mg per serving, with a 10% variance allowance). It mandates testing for harmful substances including pesticides, molds, and PFAS, and requires detailed record-keeping of test results. The bill also directs a portion of adult-use cannabis tax revenue to fund medical cannabis programs and creates a study group to review the program’s effectiveness. These changes directly affect medical cannabis patients, dispensaries, and caregivers in Maine by aligning safety protocols with adult-use standards.
This bill exempts certain over-the-counter (OTC) medicines from Maine's sales tax starting January 1, 2026. It applies to FDA-approved OTC medicines meeting specific labeling requirements, including antacids, contraceptive products, allergy medications, eye/ear/nose treatments, and opioid antagonists. The exemption covers medicines sold directly to consumers without a prescription, but excludes cannabis products. This change affects Maine residents purchasing these specific OTC health products, reducing their out-of-pocket costs for essential medications.
This bill requires the Maine Department of Health and Human Services to amend its rules so that hospitals participating in MaineCare receive at least 75% of the amount they report for costs within 90 days of submitting their cost reports. It directly affects hospitals that submit cost reports for reimbursement under MaineCare, the state's Medicaid program. The change mandates this timeline and reimbursement rate through updates to the MaineCare Benefits Manual (Chapter 101, Chapter III, Section 45) and must be implemented using existing department resources without new state funding.
LD 182 requires Maine's Department of Health and Human Services to set MaineCare reimbursement rates for Maine Veterans' Homes on a per-resident daily basis. This directly affects veterans' facilities (including nursing homes and residential care facilities operated by Maine Veterans' Homes) and ensures MaineCare covers the portion of their operating costs tied to residents receiving MaineCare benefits. The bill mandates annual inflation adjustments to these rates and allows the department to use data from other states or hire third parties to establish them. It does not change eligibility but standardizes how costs for covered residents are calculated and reimbursed.
This bill expands Maine's 1998 Special Retirement Plan to include specific mental health workers. It adds two new categories of employees: (1) those providing direct care to people needing mental health services in community or residential settings, and (2) those offering crisis outreach services to adults with developmental or intellectual disabilities. The change applies to Department of Health and Human Services employees hired on or after October 1, 2025, who meet these role definitions. These workers will now qualify for the same retirement benefits as existing categories under the 1998 plan, including options for service-based retirement at age 55 with 10 years of service or 25 years total service.
This bill amends Maine's optometry practice laws to clarify the scope of services optometrists can provide. It explicitly permits optometrists to prescribe hydrocodone combination products and other controlled substances (such as schedule III-V drugs) for eye conditions, while listing specific procedures excluded from optometry practice (e.g., corneal transplants, retinal surgery, and surgeries requiring general anesthesia). The bill also requires optometrists to meet board-established credentialing standards before performing any ophthalmic surgery or laser procedures. These changes directly affect Maine optometrists by defining their prescribing authority and procedural boundaries.
LD 882 adds critical incident stress management peer support to the legal definition of "health care" in Maine law, protecting communications between these providers and people they assist. The bill designates peer support providers as mandatory reporters for suspected child abuse or neglect, requiring them to report such cases under state law. It establishes a legal privilege preventing these providers from being forced to testify about confidential communications during peer support sessions, except when a person's physical or mental condition is in question or a court deems disclosure necessary for justice. This protects the confidentiality of sensitive support conversations while ensuring child safety reporting obligations are met.
LD 697 directs Maine's Prescription Drug Affordability Board to set annual spending targets for prescription drugs purchased by state and local government health plans (excluding MaineCare), using a formula based on a 10-year average of medical care costs plus inflation, minus savings. The board must assess cost-reduction strategies, including reference-based pricing - which aligns drug prices with those in other regions - and establish a 12-member advisory council with representatives from state agencies, labor unions, and consumer groups to advise on setting targets and methods. The board will also identify public payors (state, county, and municipal health plans) likely to exceed the spending targets.
